Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Nalini Bora

Concepts (240)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Uveitis, Anterior
10
2019
28
3.320
 Why?
Autoimmune Diseases
11
2019
101
3.270
 Why?
Choroidal Neovascularization
17
2022
54
3.240
 Why?
Complement System Proteins
7
2014
46
1.960
 Why?
Macular Degeneration
10
2016
47
1.940
 Why?
Disease Models, Animal
22
2022
1455
1.820
 Why?
Autoantigens
5
2009
58
1.280
 Why?
Complement Activation
8
2010
42
1.270
 Why?
Uveitis
5
2009
26
1.090
 Why?
Rats, Inbred Lew
13
2019
69
1.090
 Why?
Immune Tolerance
6
2009
96
1.060
 Why?
Animals
41
2022
13187
0.920
 Why?
Transforming Growth Factor beta2
5
2019
17
0.880
 Why?
Rats
16
2019
3305
0.780
 Why?
Choroid
5
2012
22
0.720
 Why?
Geographic Atrophy
2
2016
7
0.670
 Why?
Complement Factor B
2
2011
10
0.660
 Why?
Complement Pathway, Alternative
2
2011
9
0.660
 Why?
Antigens, Surface
3
2010
54
0.650
 Why?
T-Lymphocytes, Regulatory
2
2009
86
0.650
 Why?
Eye Diseases
3
2008
38
0.640
 Why?
Recombinant Proteins
4
2019
486
0.620
 Why?
Adiponectin
6
2022
64
0.600
 Why?
CD4-Positive T-Lymphocytes
2
2011
164
0.600
 Why?
Complement Membrane Attack Complex
6
2011
19
0.580
 Why?
Eye
4
2006
31
0.580
 Why?
Collagen Type I
2
2009
89
0.550
 Why?
Antigens, Neoplasm
2
2008
151
0.500
 Why?
Reverse Transcriptase Polymerase Chain Reaction
8
2014
595
0.490
 Why?
Neovascularization, Pathologic
3
2012
161
0.480
 Why?
Lasers
8
2011
123
0.480
 Why?
Ethanol
3
2008
340
0.480
 Why?
Blotting, Western
6
2016
601
0.460
 Why?
Complement C4
2
2011
9
0.450
 Why?
Interleukin-2 Receptor alpha Subunit
2
2009
9
0.430
 Why?
Male
25
2020
25241
0.420
 Why?
Mice
16
2022
5739
0.420
 Why?
Receptors, Cell Surface
2
2010
122
0.410
 Why?
Honey
1
2011
8
0.400
 Why?
Keratitis
1
2011
11
0.390
 Why?
Adoptive Transfer
5
2011
40
0.390
 Why?
Pseudomonas Infections
1
2011
48
0.390
 Why?
Eye Injuries
1
2011
26
0.380
 Why?
Wound Healing
2
2016
204
0.380
 Why?
Eye Infections, Bacterial
1
2011
31
0.380
 Why?
Vascular Endothelial Growth Factor A
8
2016
201
0.380
 Why?
Models, Biological
1
2014
727
0.380
 Why?
Down-Regulation
3
2007
348
0.370
 Why?
Complement C3
4
2014
24
0.370
 Why?
Complement Factor H
2
2010
10
0.370
 Why?
Mice, Inbred C57BL
11
2020
1816
0.370
 Why?
Cell Proliferation
6
2020
1007
0.370
 Why?
Protein Processing, Post-Translational
2
2009
171
0.360
 Why?
Apoptosis
5
2014
1101
0.360
 Why?
Enzyme-Linked Immunosorbent Assay
5
2016
244
0.360
 Why?
Mice, Knockout
5
2016
841
0.340
 Why?
Epitopes
1
2009
59
0.340
 Why?
Complement Inactivator Proteins
2
2006
5
0.330
 Why?
Immunohistochemistry
5
2014
973
0.320
 Why?
Wet Macular Degeneration
2
2022
12
0.310
 Why?
Cattle
4
2009
210
0.310
 Why?
Acyltransferases
2
2006
29
0.300
 Why?
Complement C3b
2
2006
7
0.290
 Why?
Retinal Pigment Epithelium
3
2016
18
0.280
 Why?
Esters
1
2006
22
0.270
 Why?
Immunity, Innate
1
2007
104
0.260
 Why?
Angiogenesis Inhibitors
2
2020
187
0.260
 Why?
Fatty Acids
1
2006
146
0.260
 Why?
Lipoxygenase Inhibitors
1
2005
6
0.250
 Why?
Prostaglandin-Endoperoxide Synthases
1
2005
26
0.250
 Why?
Cyclooxygenase Inhibitors
1
2005
39
0.250
 Why?
Nitric Oxide Synthase
1
2005
75
0.250
 Why?
Immunologic Factors
1
2006
114
0.250
 Why?
Antigens, CD
2
2003
219
0.250
 Why?
Carboxylic Ester Hydrolases
1
2003
7
0.230
 Why?
Injections, Intravenous
3
2009
140
0.230
 Why?
Mutagenesis, Site-Directed
1
2003
99
0.230
 Why?
Avian Proteins
1
2003
4
0.220
 Why?
Antigen-Presenting Cells
1
2003
26
0.220
 Why?
Blood Proteins
1
2003
82
0.210
 Why?
Polyethylene Glycols
2
2014
93
0.210
 Why?
Cytokines
3
2011
612
0.200
 Why?
Injections, Intraocular
2
2019
6
0.200
 Why?
Myocardium
1
2003
436
0.190
 Why?
Trabeculectomy
1
2020
8
0.190
 Why?
Trityl Compounds
1
2020
2
0.190
 Why?
Butyric Acid
1
2020
10
0.180
 Why?
Acetamides
1
2020
20
0.180
 Why?
Glaucoma
1
2020
32
0.180
 Why?
Transforming Growth Factor beta
3
2006
144
0.170
 Why?
Peptide Fragments
2
2012
215
0.170
 Why?
Endotoxins
2
2011
34
0.170
 Why?
Nicotine
2
2012
187
0.170
 Why?
Melanins
2
2011
27
0.160
 Why?
Specific Pathogen-Free Organisms
2
2009
18
0.160
 Why?
Immunoglobulin G
2
2011
186
0.160
 Why?
Thalidomide
1
2020
377
0.150
 Why?
RNA, Small Interfering
3
2010
215
0.150
 Why?
Pigment Epithelium of Eye
2
2010
8
0.150
 Why?
Humans
16
2022
49974
0.150
 Why?
Lymph Nodes
2
2009
260
0.140
 Why?
Gene Expression Regulation
3
2014
976
0.140
 Why?
T-Lymphocytes
1
2019
338
0.140
 Why?
Retinal Degeneration
1
2016
11
0.140
 Why?
Alcohol Drinking
2
2008
224
0.130
 Why?
Chemokine CCL2
2
2016
70
0.130
 Why?
RNA, Messenger
3
2010
1105
0.130
 Why?
Amino Acid Sequence
3
2009
585
0.130
 Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2016
121
0.120
 Why?
Aspirin
1
2016
114
0.120
 Why?
Photoreceptor Cells, Vertebrate
1
2014
3
0.120
 Why?
Peptides
2
2022
223
0.120
 Why?
Follow-Up Studies
2
2011
2182
0.110
 Why?
In Situ Nick-End Labeling
2
2014
57
0.110
 Why?
Vascular Endothelial Growth Factors
1
2012
15
0.100
 Why?
Molecular Sequence Data
2
2004
792
0.100
 Why?
Receptors, Adiponectin
3
2022
10
0.100
 Why?
Membrane Glycoproteins
2
2003
240
0.100
 Why?
Proliferating Cell Nuclear Antigen
3
2022
75
0.100
 Why?
Administration, Topical
1
2011
56
0.100
 Why?
Cornea
1
2011
52
0.100
 Why?
Pseudomonas aeruginosa
1
2011
72
0.100
 Why?
Lipoproteins, LDL
1
2012
170
0.090
 Why?
Endothelium, Vascular
1
2012
252
0.090
 Why?
Drug Carriers
1
2011
67
0.090
 Why?
Fluorescent Antibody Technique
1
2010
108
0.090
 Why?
Antibodies, Monoclonal, Humanized
1
2012
225
0.090
 Why?
RNA
1
2011
170
0.090
 Why?
Autoantibodies
1
2011
116
0.090
 Why?
Microscopy, Confocal
3
2005
88
0.090
 Why?
Lymphocyte Depletion
1
2009
8
0.090
 Why?
Immunization
1
2009
67
0.090
 Why?
Cell Membrane
1
2010
248
0.080
 Why?
Forkhead Transcription Factors
1
2009
112
0.080
 Why?
Lymphocyte Count
1
2008
21
0.080
 Why?
Interleukin-2
1
2008
72
0.080
 Why?
Coculture Techniques
1
2008
146
0.080
 Why?
Treatment Outcome
2
2011
5141
0.080
 Why?
Caspase 8
1
2007
12
0.080
 Why?
Caspase 9
1
2007
15
0.080
 Why?
Cell Line
3
2020
1000
0.080
 Why?
Cytochromes c
1
2007
29
0.080
 Why?
Diet
2
2016
566
0.080
 Why?
bcl-2-Associated X Protein
1
2007
56
0.070
 Why?
Caspase 3
1
2007
97
0.070
 Why?
Growth Substances
1
2007
23
0.070
 Why?
Anterior Chamber
1
2007
8
0.070
 Why?
Proto-Oncogene Proteins c-bcl-2
1
2007
129
0.070
 Why?
Complement C5
1
2006
3
0.070
 Why?
Complement C1q
1
2006
9
0.070
 Why?
Receptors, Complement
1
2006
3
0.070
 Why?
Complement C3-C5 Convertases
1
2006
3
0.070
 Why?
Oligodeoxyribonucleotides, Antisense
1
2006
4
0.070
 Why?
Antibodies, Blocking
1
2006
8
0.070
 Why?
Intercellular Signaling Peptides and Proteins
1
2007
104
0.070
 Why?
Cyclin E
1
2006
6
0.070
 Why?
Cyclin-Dependent Kinase 2
1
2006
16
0.070
 Why?
Macrophage-1 Antigen
1
2006
9
0.070
 Why?
Fluorescent Antibody Technique, Indirect
1
2006
21
0.070
 Why?
Inflammation
1
2010
604
0.070
 Why?
Recombinant Fusion Proteins
1
2007
181
0.070
 Why?
Chemokines
1
2006
77
0.070
 Why?
Models, Molecular
1
2007
338
0.070
 Why?
Risk Factors
1
2014
3613
0.070
 Why?
Cell Adhesion Molecules
1
2006
88
0.070
 Why?
Arachidonate 5-Lipoxygenase
1
2005
4
0.060
 Why?
Collagen
1
2007
206
0.060
 Why?
Cyclooxygenase 2 Inhibitors
1
2005
19
0.060
 Why?
Guanidines
1
2005
31
0.060
 Why?
Injections, Subcutaneous
1
2005
54
0.060
 Why?
Nitric Oxide Synthase Type II
1
2005
66
0.060
 Why?
Cyclooxygenase 2
1
2005
45
0.060
 Why?
Flow Cytometry
1
2007
476
0.060
 Why?
Macrophages
1
2007
363
0.060
 Why?
Fibroblast Growth Factors
1
2005
47
0.060
 Why?
Up-Regulation
1
2006
452
0.060
 Why?
Immune Sera
1
2004
17
0.060
 Why?
Pyrazoles
1
2005
113
0.060
 Why?
Organ Specificity
1
2004
108
0.060
 Why?
Sequence Homology
1
2003
20
0.060
 Why?
COS Cells
1
2003
74
0.060
 Why?
Sulfonamides
1
2005
129
0.060
 Why?
Bruch Membrane
1
2003
1
0.060
 Why?
Enzyme Activation
1
2003
276
0.060
 Why?
Hypersensitivity, Delayed
1
2003
21
0.050
 Why?
Disease Progression
1
2006
825
0.050
 Why?
Interleukin-12
1
2003
31
0.050
 Why?
Fluorescein-5-isothiocyanate
1
2022
7
0.050
 Why?
Ophthalmic Solutions
1
2022
18
0.050
 Why?
Interleukin-10
1
2003
84
0.050
 Why?
Structure-Activity Relationship
1
2003
395
0.050
 Why?
Antibodies, Monoclonal
1
2006
459
0.050
 Why?
Cells, Cultured
3
2012
1573
0.050
 Why?
Antibodies, Neutralizing
2
2012
64
0.050
 Why?
Time Factors
3
2014
2903
0.050
 Why?
Tetrazolium Salts
1
2020
13
0.050
 Why?
Rats, Inbred BN
2
2012
17
0.050
 Why?
Immunotherapy
1
2003
238
0.050
 Why?
Mitomycin
1
2020
20
0.050
 Why?
Lidocaine
1
2020
49
0.050
 Why?
Human Umbilical Vein Endothelial Cells
1
2020
90
0.040
 Why?
Aging
1
2004
687
0.040
 Why?
Endothelial Cells
2
2012
269
0.040
 Why?
Mutation
1
2003
1294
0.040
 Why?
Immunoenzyme Techniques
2
2010
143
0.040
 Why?
Female
1
2016
26472
0.030
 Why?
Complement C1 Inhibitor Protein
1
2014
3
0.030
 Why?
Aminopeptidases
1
2014
17
0.030
 Why?
Matrix Metalloproteinase 9
1
2014
88
0.030
 Why?
Serine Endopeptidases
1
2014
52
0.030
 Why?
Autophagy
1
2014
169
0.030
 Why?
Bungarotoxins
1
2012
6
0.030
 Why?
Intravitreal Injections
1
2012
35
0.030
 Why?
Vascular Endothelial Growth Factor Receptor-2
1
2012
32
0.030
 Why?
Aged
2
2022
9310
0.030
 Why?
Receptors, Nicotinic
1
2012
76
0.020
 Why?
Oxidation-Reduction
1
2012
322
0.020
 Why?
Complement C9
1
2011
3
0.020
 Why?
Polymerase Chain Reaction
1
2012
453
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2012
411
0.020
 Why?
Analysis of Variance
1
2012
562
0.020
 Why?
Vision, Ocular
1
2010
11
0.020
 Why?
Dose-Response Relationship, Drug
1
2014
1376
0.020
 Why?
Transcriptome
1
2012
315
0.020
 Why?
Gene Expression
1
2012
609
0.020
 Why?
Protein Structure, Tertiary
1
2009
253
0.020
 Why?
Models, Animal
1
2009
233
0.020
 Why?
Immune System
1
2004
44
0.010
 Why?
Immunoblotting
1
2003
118
0.010
 Why?
Thromboplastin
1
2003
6
0.010
 Why?
Gene Library
1
2003
43
0.010
 Why?
Cell Adhesion
1
2003
158
0.010
 Why?
Adenoviridae
1
2003
51
0.010
 Why?
DNA, Complementary
1
2003
135
0.010
 Why?
Genetic Vectors
1
2003
125
0.010
 Why?
Retina
1
2003
64
0.010
 Why?
Swine
1
2003
393
0.010
 Why?
Protein Binding
1
2003
660
0.010
 Why?
Liver
1
2003
1115
0.010
 Why?
Middle Aged
1
2003
12069
0.000
 Why?
Bora's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (240) concept(s)
_
Co-Authors Expand Description
See all (4) people
_
Similar People Expand Description
See all (38) people
_
Same Department Expand Description
Search Department